404 results on '"Garan, A.R."'
Search Results
52. Cardiac Recovery in Patients with Adriamycin-Induced Cardiomyopathy After Left Ventricular Assist Device Support
53. Incidence and Outcomes of Cardiac Surgery After Orthotopic Heart Transplantation
54. A Prospective Comparison of Veno-Arterial Extra-Corporeal Membrane Oxygenation and a Percutaneous Ventricular Assist Device for Cardiogenic Shock Following Acute Myocardial Infarction
55. Predictors of Neurologic Outcomes After Extracorporeal Cardiopulmonary Resuscitation
56. Outcome of Cardiac Retransplantation for Late Allograft Failure: A Fifteen-Year Single Center Experience
57. Reduced 24-hour Blood Pressure Variability is Associated With Lower Pulse Pressure in Patients on Continuous Flow Left Ventricular Assist Device Support
58. Differences In 24-Hour Vascular Hemodynamic Profiles Among Healthy Subjects, Heart Failure, Left Ventricular Assist Device and Heart Transplant Patients
59. Palliative Care Consultation in Cardiogenic Shock Requiring Short-term Mechanical Circulatory Support- A Retrospective, Description of Timing and Utilization From a Single Institution
60. Usefulness of Near-infrared Reflectance Spectroscopy to Assess Lower-limb Perfusion on Femoral Veno-arterial Extracorporeal Membrane Oxygenation
61. Predictors of Postoperative Vasoplegia in Patients Receiving Left Ventricular Assist Devices
62. Mechanical Circulatory Support for Late Cardiac Allograft Failure
63. Long-term Outcome of Patients Bridged to Recovery After Short-term Mechanical Circulatory Support for Cardiogenic Shock
64. Natural Polyreactive Antibodies and Inflammatory Markers Following Left Ventricular Assist Device Implantation
65. Early and Late Outcomes of Subcostal Exchange of HeartMate II Left Ventricular Assist Device: A Word of Caution
66. Post-Transplant Outcomes of Patients Initially Receiving Left Ventricular Assist Device as Either Bridge to Candidacy or Destination Therapy
67. Laterality of Cerebral Artery Hemodynamics in Continuous-Flow LVAD Patients: A Pilot Study in Relation to Stroke
68. Estimation of Mean Arterial Pressure in HeartMate II Patients Using Doppler Blood Pressure and Pump Speed
69. Ten-year Experience With CentriMag Ventricular Assist Device Use in Acute Myocardial Infarction and Cardiogenic Shock
70. Relationship Between Oral Microbiota, Inflammation and Congestion Among Advanced Heart Failure Patients
71. Increased Aortic Stiffness is Associated with Higher Rates of Stroke, GI-bleeding and Pump Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients
72. Hemodynamic Determinants of Decline in Renal Function During Left Ventricular Assist Device Support
73. Predictive Value of Mean Arterial Pressure Versus Systolic Blood Pressure and Visit-To-Visit Blood Pressure Variability for Stroke and Pump Thrombosis in HeartMate II Patients
74. Gut Microbiome-Generated Metabolite Trimethylamine-N-Oxide is Reduced After Heart Transplantation and Continuous Flow Left Ventricular Assist Device Therapy in Advanced Heart Failure Patients
75. Pulmonary Artery Decoupling Further Enhances Discriminatory Power of Pulmonary Vascular Resistance in Patients Bridged to Transplant with Left Ventricular Assist Devices
76. Transmission of Pulsatility Into the Brain of Patients with Continuous-Flow Left Ventricular Assist Devices
77. A Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices
78. Differential Effects of Carvedilol vs. Metoprolol on Mortality and Adverse Events in Left Ventricular Assist Devices Patients
79. Creatinine versus Cystatin C Based Equations for Estimation of Renal Function in Left Ventricular Assist Device Patients
80. Pre-Transplant Estimated Glomerular Filtration Rate Less Than 40 Provides Similar Risks of Post-transplant Mortality Both in LVAD and Non-LVAD Heart Transplant Recipients
81. Safety of Right Heart Catheterization via Brachial Vein Approach in Patients With Left Ventricular Assist Device on Warfarin Therapy
82. Advanced Heart Failure Patients With Left Ventricular Assist Devices and Heart Transplantation Have Altered Oral Microbial Diversity Alongside Endotoxemia, Inflammation and Oxidative Stress
83. Prognostic Implications of Intermediate Hemolysis in Continuous Flow Left Ventricular Assist Device Patients
84. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported with Left Ventricular Assist Devices
85. Endoscopic Evaluation in Patients with CF-LVADs with Gastrointestinal Bleeding: Are We Ready for a Paradigm Shift to Improve Care?
86. How Old Is Too Old? The Influence of Advanced Age on VA-ECMO Outcomes
87. Dose-Dependent Association Between Amiodarone and Primary Graft Dysfunction in Heart Transplantation
88. Pulmonary Vascular Resistance Is Not an Independent Predictor of Post-Transplant Outcome in Bridge-to-Transplant Patients; It's Time to Re-Evaluate Our Current Heart Transplant Eligibility
89. VA ECMO as a Bridge to Transplantation: Emergent Eligibility and Outcomes
90. Novel Palliative Care Integration Program increases Days Alive and Out of Hospital and Reduces Inpatient Direct Costs Among Left Ventricular Assist Device Patients
91. Bridge-to-Transplant LVAD or Primary Heart Transplantation in Young Patients? Both Offer Similar Mid-Term Survival
92. Concomitant Tricuspid Valve Replacement with a Continuous-Flow Left Ventricular Assist Device in Patients with Severe Tricuspid Regurgitation and Marginal Right Ventricular Function
93. Circadian Variation in Hemodynamics and Device Parameters in HeartMate II Patients
94. Is the ISHLT-Suggested Inotrope Score a Predictor of In-Hospital Mortality After Heart Transplantation?
95. Vasoactive-Inotropic Score Is Associated with In-Hospital Mortality in Continuous Flow Left Ventricular Assist Device Patients
96. Predictors of Ventricular Recovery After Acute Myocardial Infarction Complicated by Cardiogenic Shock
97. Use of Pre-Device Exchange Computed Tomography Angiography for Left Ventricular Assist Device Thrombosis
98. Predictors of Mortality in Cardiogenic Shock Patients Treated with Extra-Corporeal Cardiopulmonary Resuscitation
99. The New Heart Allocation System: Implications on Patients with Restrictive Cardiomyopathy in the UNOS Registry
100. Outcomes of Multiple Concomitant Valve Procedures in Patients Receiving Continuous-Flow Left Ventricular Assist Device
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.